Agenda Item 3. Review of progress in the implementation of the Convention and the Strategic Plan for Biodiversity 2011-2020
Statements deliver as CBD Alliance during the 24th meeting of the Subsidiary Body on Scientific, Technical and Technological Advise
SBSTTA 24 CBDA Statements
Statements delivered during the 3rd meeting of the Subsidiary Body on Implementation
Agenda Item 3. Post 2020 Global Biodiversity Framework
Civil society organizations and experts call draft new global action plan on biodiversity conservation disappointingly weak and unacceptable
Through our platform users can stay updated on the CBD industry and access detailed data, trends and statistics on this fast-moving sector. We also offer standalone reports and data packages and customised consultancy and research.
The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.
Market and regulatory premium data and analysis for the cannabidiol (CBD) sector worldwide. We provide actionable insights and in-depth information on pricing, distribution, industry updates and legal landscape.
Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.